Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction

Published:2016-06-15 Issue:2 Volume:40 Page:158-164
ISSN:0140-7783
Container-title:Journal of Veterinary Pharmacology and Therapeutics
language:en
Short-container-title:J. vet. Pharmacol. Therap.

Author:

McFarlane D.¹,Banse H.¹,Knych H. K.²,Maxwell L. K.¹

Affiliation:

1. Center for Veterinary Health Sciences; Physiological Sciences; Oklahoma State University; Stillwater OK USA

2. K.L. Maddy Equine Analytical Chemistry Laboratory; School of Veterinary Medicine; University of California; Davis CA USA

Publisher

Wiley

Subject

General Veterinary,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvp.12339/fullpdf

Reference20 articles.

1. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia;Beech;Journal of American Veterinary Medical Association,2007

2. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease);Donaldson;Journal of Veterinary Internal Medicine,2002

3. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses;Donaldson;Journal of Veterinary Internal Medicine,2005

4. FDA FOIADrugSummaries/UCM280354 http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/UCM280354.pdf

5. Frank , N. Andrews , F. Durham , A Kritchevsky , J. McFarlane , D. Schott , H 2015 Recommendations for the diagnosis and treatment of pituitary pars intermedia dysfunction (PPID) https://sites.tufts.edu/equineendogroup/files/2015/12/2015-10-16_EEG-2015-recommendations.pdf

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction;Frontiers in Veterinary Science;2024-03-06

2. Influence of feeding and other factors on adrenocorticotropin concentration and thyrotropin‐releasing hormone stimulation test in horses and ponies;Equine Veterinary Journal;2023-11-27

3. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction;Equine Veterinary Journal;2023-10-05

4. Pharmacokinetic properties of pergolide mesylate following single and multiple‐dose administration in donkeys ( Equus asinus );Equine Veterinary Journal;2023-01-18

5. Pituitary Pars Intermedia Dysfunction (PPID) in Horses;Veterinary Sciences;2022-10-10